ZEN-3694
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for ZEN-3694, covering 2025-07-22 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer [Phase 1]